Immune modulatory effects of ibrutinib in pancreatic ductal adenocarcinoma

被引:0
|
作者
Sinha, M. [1 ]
Griffith, M. [1 ]
Betts, C. [2 ]
Choe, G. [2 ]
Sivagnanam, S. [2 ]
Cheung, A. [1 ]
Tamaki, W. [1 ]
Liu, E. [1 ]
Sudduth-Klinger, J. [1 ]
Vaccaro, G. [2 ]
Lopez, C. [2 ]
Fong, L. [1 ]
Coussens, L. [3 ]
Tempero, M. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P - 146
引用
收藏
页码:40 / 40
页数:1
相关论文
共 50 条
  • [1] Effects of curcumin on pancreatic ductal adenocarcinoma
    Vaskas, Adrianna M.
    Fraietta, Joseph A.
    Long, Kristen B.
    CANCER RESEARCH, 2019, 79 (24)
  • [2] Peripheral blood immune phenotypes in pancreatic ductal adenocarcinoma
    Pavelko, Kevin D.
    Villasboas, Jose C.
    Taylor, William R.
    Doering, Karen A.
    Kisiel, John B.
    Majumder, Shounak
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
    LiKe-Yu
    YuanJia-Long
    TraftonDiego
    WangJian-Xin
    NiuNan
    YuanChun-Hui
    LiuXu-Bao
    ZhengLei
    慢性疾病与转化医学(英文), 2020, (01) : 6 - 17
  • [4] Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
    Ahmed, Azaz
    Klotz, Rosa
    Koehler, Sophia
    Giese, Nathalia
    Hackert, Thilo
    Springfeld, Christoph
    Jaeger, Dirk
    Halama, Niels
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] The basis of immune suppression in murine pancreatic ductal adenocarcinoma
    Fearon, Douglas T.
    CANCER RESEARCH, 2015, 75
  • [6] The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
    Tulyte, Skaiste
    Characiejus, Dainius
    Matuzeviciene, Reda
    Janiulioniene, Ausra
    Radzevicius, Mantas
    Zvirblis, Tadas
    Sileikis, Audrius
    ANTICANCER RESEARCH, 2022, 42 (06) : 3067 - 3073
  • [7] The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
    Loch, Florian N. N.
    Kamphues, Carsten
    Beyer, Katharina
    Schineis, Christian
    Rayya, Wael
    Lauscher, Johannes C. C.
    Horst, David
    Dragomir, Mihnea P. P.
    Schallenberg, Simon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [8] Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
    Gartrell, Robyn D.
    Enzler, Thomas
    Kim, Pan S.
    Fullerton, Benjamin T.
    Fazlollahi, Ladan
    Chen, Andrew X.
    Minns, Hanna E.
    Perni, Subha
    Weisberg, Stuart P.
    Rizk, Emanuelle M.
    Wang, Samuel
    Oh, Eun Jeong
    Guo, Xinzheng, V
    Chiuzan, Codruta
    Manji, Gulam A.
    Bates, Susan E.
    Chabot, John
    Schrope, Beth
    Kluger, Michael
    Emond, Jean
    Rabadan, Raul
    Farber, Donna
    Remotti, Helen E.
    Horowitz, David P.
    Saenger, Yvonne M.
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [9] Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
    Marc Hilmi
    Laurent Bartholin
    Cindy Neuzillet
    World Journal of Gastroenterology, 2018, (20) : 2137 - 2151
  • [10] The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
    Lekan, Alexander A.
    Weiner, Louis M.
    CANCERS, 2024, 16 (03)